Cooper Companies | COO - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.3B 380M 2026-03
Align Technology USD 303.5M 60.47M 2026-03
AtriCure USD 31.94M 3.22M 2026-03
Avanos Medical USD 88M 6.9M 2026-03
Bausch Health Companies USD 979M 55M 2026-03
Baxter International USD 1.81B 587M 2026-03
Bayer EUR 5.23B 731M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 393.8M 17M 2026-03
Dentsply International USD 453M 65M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
Haemonetics USD 136.58M 4.01M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Novartis USD 3.54B 7M 2025-12
ResMed USD 551.67M 4.17M 2026-03
STAAR Surgical USD 24.66M 10.6M 2026-03
Steris USD 891.3M 50.6M 2026-03
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Utah Medical Products USD 3.78M 419K 2025-12
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03